News

Merck

Merck

January

2020

Merck buy a license of Makya 

UCB

UCB

January

2020

Iktos initiate a research collaboration with UCB across three different projects. In September 2020, UCB buy a license of Spaya

Pfizer

Pfizer

August

2020

Pfizer buy a license of Kaya (Python version of Makya)

Alkermes

Alkermes

July

2020

Alkermes buy a license of Kaya (Python version of Makya)

Blueprint

Blueprint

June

2020

Iktos initiates a research
collaboration with Blueprint medicines

Lundbeck

Lundbeck

July

2020

Lundbeck buy a license of Kaya (Python version of Makya)

LEO Pharma

LEO Pharma

February

2020

Iktos initiates a research
collaboration with LEO Pharma

Awards

March

2018

Winner of the French

“Worldwide Innovation Challenge Phase 2”.

Iktos will benefit from non-dilutive funding from Bpifrance for 900k€

October

2017

Iktos wins the Innov’Up Proto challenge,

sponsored by the Paris region,

and will get a 100k€

non-dilutive funding.

March

2017

Iktos is labelled by
Cap Digital for
its application to
CMI and CIN challenges

They talk about us